DA
SPRY icon

Denali Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Denali Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-87,500
Closed -$480K – 498
2023
Q4 		$480K Buy
+87,500
New +$480K 0.15% 145